{"id":"W4379979901","doi":"10.1002/hon.3165_463","title":"POLATUZUMAB AND THE PROGRESSION‐FREE SURVIVAL (PFS) PREDICAMENT: A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT AGENCY (HTA) REVIEWS","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Cost-effectiveness analysis; Progression-free survival; Regimen; Cost–benefit analysis; Agency (philosophy); Health technology; Oncology; Family medicine; Internal medicine; Health care; Overall survival; Cost effectiveness; Political science; Economic growth; Economics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.03335062,0.0007121076,0.003120229,0.02510277,0.0003085413,0.004175164,0.0007335152,0.001167539,0.002470173],"category_scores_gemma":[0.137579,0.0005244551,0.00563593,0.02958586,0.0006486941,0.002476774,0.001297658,0.00083376,0.0002579535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004725244,"about_ca_system_score_gemma":0.004373664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003370759,"about_ca_topic_score_gemma":0.0056836,"domain_scores_codex":[0.9523481,0.02329836,0.01141619,0.002189673,0.009955624,0.0007919305],"domain_scores_gemma":[0.7071332,0.209396,0.05991213,0.002826949,0.01901441,0.001717338],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.01284461,0.0002188202,0.1010848,0.2547654,0.08032899,0.0006023342,0.002335198,0.001693369,0.001356702,0.003934533,0.02388938,0.5169458],"study_design_scores_gemma":[0.003794654,0.005483162,0.398944,0.1942168,0.2172483,0.002876082,0.003360122,0.002553062,0.002388987,0.002747186,0.1659728,0.0004148746],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0320786,0.9568129,0.0003722735,0.001903023,0.000133766,0.0003124178,0.005041705,0.00002675672,0.003318606],"genre_scores_gemma":[0.4657492,0.5234203,0.002516209,0.001891448,0.0006642707,0.000943153,0.004203408,0.00007023689,0.0005417389],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9748972,"threshold_uncertainty_score":0.1763771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5361641187209318,"score_gpt":0.5553214294596311,"score_spread":0.01915731073869931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}